Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Multiple Sclerosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Multiple Sclerosis
    TopAbstracts in Multiple Sclerosis 10/29/2009 - (DGNews)
    Experimental Drug Reduces Pseudobulbar Affect in Patients With MS, ALS: Presented at ANA - (DGDispatch)
    TopAbstracts in Multiple Sclerosis 10/15/2009 - (DGNews)
    Glatiramer Acetate Treatment Reduces Risk of Early MS Progressing to Clinically Definite Disease - (DGNews)
    TopAbstracts in Multiple Sclerosis 10/01/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Multiple Sclerosis
    Evidence-Based Update for NPs and PAs in the Diagnosis and Management of Multiple Sclerosis
    Multiple Sclerosis and Managed Care: Evidence-Based Approaches to Optimize Formulary Design and Patient Outcomes

    Webcasts/CME archive

     Recent cases - Multiple Sclerosis
      Encephalomyelitis Mimicking Multiple Sclerosis Associated with Chronic Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation
      Progressive Primary Form of Multiple Sclerosis: Clinical and Radiological Improvement with Methylprednisolone in Continuous Pulsetherapy in One Case for 16 Years
      Burrowing of Urinary Bladder Wall by the Tip of a Size 22 Fr Silicone Foley Catheter in an Adult Male Patient With Multiple Sclerosis and Suprapubic Cystostomy: Should Caution be Exercised in Using a Size 22 Fr Silicone Foley Catheter for Long-Term Drainage of Neuropathic Bladder?
      Central Auditory Evaluation in Multiple Sclerosis: Case Report
      Recurrent Acute Hepatitis in Patient Receiving Pulsed Methylprednisolone for Multiple Sclerosis

      Cases archive
        




      my personal edition > multiple sclerosis > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Stretching Exercises Enhance Botox Therapy for Spasticity in Multiple Sclerosis: Presented at ECTRIMS

      By Bruce Sylvester

      THESSALONIKI, GREECE -- October 3, 2005 -- For multiple sclerosis (MS) patients with spasticity, a stretching exercise program for 15 consecutive days following injection of botulinum toxin type A (Botox) adds to the benefits of the injection.

      Researchers reported this finding here on September 29th at the 21st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

      "This is 1 of the first studies to look at the effects of Botox treatment for MS spasticity, and we have also looked at the enhancement of the treatment through physiotherapy," said investigator and presenter Marina Giovannelli, MD, researcher, Saint Andreas Hospital MS Centre, University of Rome, Rome, Italy.

      "The most important findings are that the botulinum toxin injections are very helpful to [patients with spasticity], and that this efficacy is significantly enhanced by specific stretching exercise physiotherapy following each injection treatment, which are repeated every 3 months."

      The researchers studied 36 women and 4 men with MS, mean age of 48.7 years (range from 26 years to 63 years) and progressive disease. Their mean score on the Expanded Disability Status Scale (EDSS) was 6.0 (range from 3.5 to 7.5).

      All of the subjects had severe spasticity, as measured by Ashworth scale (15 patients with a score of 3 and 25 patients with a score of 4). They were all treated with type A botulinum toxin (Botox) injections.

      The investigators randomised 22 patients to Botox-plus-physiotherapy program, employing stretching rehabilitation for 15 consecutive days after the injection, and 18 patients to Botox injections alone. Six patient received 100 units of Botox injected into major muscles of upper limbs and 34 received a dose of 100-300 units of Botox in the lower extremity spastic muscles.

      The researchers assessed subjects at weeks 2, 4, and 12 weeks posttreatment using the Ashworth Scale and Visual Analogue Scale for spasticity (VAS).

      "There were no differences in the baseline characteristic of the 2 groups [ie age, sex, EDSS, and dosage of Botox injected]," the authors noted

      The investigators reported a decrease of spasticity in both groups, but a significant positive group difference was found among those subjects who had received Botox in the lower extremity spastic muscles and undergone follow-up physiotherapy.

      "Our data confirm that botulinum toxin type A significantly decreases spasticity in MS," The authors concluded. "Moreover, physiotherapy characterised by stretching rehabilitation program for 15 consecutive days after the injection improved overall response to botulinum toxin injection."


      [Presentation title: Early Physiotherapy After Injection of Botulinum Toxin Increases the Beneficial Effects on Spasticity in Patients With Multiple Sclerosis. Poster # 374]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send